The role of HLA LOH in the development of Asian liver cancer by Phua, Cheryl Zi Jin

“…However, its effectiveness is limited in liver cancer treatment due to lack of understanding of the mechanisms underlying immune evasion. …”
Get full text

Liver cancer from view of physiological and medical imaging by Zakaria, Zulkarnay, Rahiman, Mohd. Hafiz Fazalul, Abdul Rahim, Ruzairi, Mansor, Muhammad Saiful Badri, Mohd. Muji, Siti Zarina

Longitudinal Imaging of Liver Cancer Using MicroCT and Nanoparticle Contrast Agents in CRISPR/Cas9-Induced Liver Cancer Mouse Model by Sang Bu An, Kwangmo Yang MD, PhD, Chang Won Kim MD, PhD, Si Ho Choi PhD, Eunji Kim, Sung Dae Kim, Jae Soo Koh

“…Conclusion: Micro-computed tomography with nanoparticle contrast is useful in evaluating the induction and characteristics of liver cancer, determining appropriate size of liver cancer for testing, and confirming therapeutic response.…”
Get full text

Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3 by Xiaojie Li, Mei Yuan, Lu Song, Yan Wang

Subjects: Get full text

Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted CAR T-cell therapy: a case report by Yun Wang, Yan Zhao, Miaoling Li, Huilian Hou, Zhijie Jian, Weizhi Li, Peijie Li, Fuquan Ma, Mengying Liu, Haibo Liu, Hui Xue

Subjects: “…primary liver cancer (PLC)…”
Get full text

Secretory Function of Kupffer Cells in Liver Cancer After Cryoablation by ZHU Yaling, YI Fengtao, DING Mengnan, ZENG Cheng, XU Zhenhua, SHAO Zhixiong, XIE Junjie

Subjects: Get full text

Wu Mengchao: A blade warrior against liver cancer by Tian Yang, Qi Zhang, Ming-Da Wang, Feng Shen

Get full text

O-glycosylation in liver cancer: Clinical associations and potential mechanisms by Kung-Hao Liang, Chau-Ting Yeh

“…Liver cancer can be an aggressive disease, and is highly prevalent in Asia and Africa. …”
Get full text

Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer by Gang Yang MM, Yuxia Yang BD, Xin Ma BD, Lijun Huang MM, Wenbin Li MM, Xuejuan Song BD, Huiqin Zhang MM, Wenwen Liu BD, Juanjuan Lu MM

“…Introduction: To explore association of excision repair cross-complementing 5 ( ERCC5 ) genetic polymorphisms with cirrhosis and liver cancer. Methods: A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). …”
Get full text

Update on perioperative management of patients undergoing surgery for liver cancer by Masaki Kaibori, Kosuke Matsui, Mitsuo Shimada, Shoji Kubo, Kiyoshi Hasegawa

Subjects: “…liver cancer…”
Get full text

Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma by Na Li, Ying Zhu

“…Liver cancer is one of the most common malignant tumors and prognosis remains poor. …”
Get full text

Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer by Hao Shen, Boqiang Liu, Junjie Xu, Bin Zhang, Yifan Wang, Liang Shi, Xiujun Cai

Subjects: Get full text

The Complement System: A Potential Therapeutic Target in Liver Cancer by Meng Yuan, Li Liu, Chenlin Wang, Yan Zhang, Jiandong Zhang

Subjects: “…liver cancer…”
Get full text

Understanding the Immunoenvironment of Primary Liver Cancer: A Histopathology Perspective by Chung A, Nasralla D, Quaglia A

“…Hepatocellular carcinoma and cholangiocarcinoma represent the majority of primary liver cancer cases. Despite advances in the development of novel anti-cancer therapies that exploit targets within the immune system, survival rates from liver cancer remain poor. …”
Get full text

Synergistic Anti-Tumor Effect of Palmitoylcarnitine and Dasatinib in Liver Cancer by Ragini Singh, Shuang Cheng, Qinghua Zeng, Santosh Kumar, Carlos Marques

Subjects: Get full text

Application of systemic treatment in conversion therapy options for liver cancer by Haoyang Bei, Weiheng Mai, Weifeng Chen, Mingyi Li, Yongguang Yang

Subjects: “…primary liver cancer…”
Get full text

Selective Inhibition of Liver Cancer Cells Using Venom Peptide by Prachi Anand, Petr Filipenko, Jeannette Huaman, Michael Lyudmer, Marouf Hossain, Carolina Santamaria, Kelly Huang, Olorunseun O. Ogunwobi, Mandë Holford

Subjects: Get full text

Cancer stem cell markers for liver cancer and pancreatic cancer by Pu Xia, Da-Hua Liu

Subjects: Get full text

Impacts of COVID-19 on Liver Cancers: During and after the Pandemic by Stephen Lam Chan, Masatoshi Kudo

“…Liver Cancer…”
Get full text

ADAM12 is an independent predictor of poor prognosis in liver cancer by Shuangqiu Du, Linlin Sun, Yun Wang, Wenhao Zhu, Jialin Gao, Wenjun Pei, Yao Zhang

“…The results showed that the ADAM12 gene was significantly and highly expressed in liver cancer tissue. The high expression of the ADAM12 gene in liver cancer tissue significantly and positively correlated with T stage, pathological stage, and residual tumour. …”
Get full text